Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro

European Respiratory Journal

Volumn 9, Issue 9, 1996, Pages 1839-1846

  Zhang, S ^a   Mohammed, Q ^a   Burbidge, A ^a   Morland, C M ^a   Roche, W R ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Bronchial myofibroblast; Eosinophil; Granulocyte macrophage colony stimulating factor

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; IN VITRO STUDY; MYOFIBROBLAST; PNEUMONIA; PRIORITY JOURNAL;

EID: 0029838626     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09091839     Document Type: Article

References (28)

1. Fukuda T, Dunnette SL, Solley GO, Farrow GM, Gleich GJ. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis 1985; 132: 981-985.
2. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage and mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137: 62-69.
3. Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-871.
4. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
5. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of eosinophil major basic protein. J Immunol 1979; 123: 2925-2927.
6. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988; 81: 776-781.
7. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982; i: 11-16.
8. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8: 349-355.
9. Morland CM, Wilson SJ, Holgate ST, Roche WR. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. Am J Respir Cell Mol Biol 1992; 6: 557-566.
10. Denburg JA, Dolovich J, Ohtoshi T, Cox G, Gauldie J, Jordana M. The microenvironmental differentiation hypothesis of airway inflammation. Am J Rhinology 1990; 4: 29-32.
11. Brewster CEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3: 507-511.
12. Zhang S, Howarth PH, Roche WR. Cytokine production by cell cultures from bronchial subepithelial myofibroblasts. J Pathol 1996; (in press).
13. Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991; 145: 105-110.
14. Chu WS, Rich S. Suppressor T-cell growth and differentiation: evidence for induced receptors on suppressor T-cells that bind a suppressor T-cell differentiation factor. J Immunol 1987; 138: 504-512.
15. Her E, Frazer J, Austen FK, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991; 88: 1982-1987.
16. Vancheri C, Gauldie J, Bienenstock J, et al. Human lung fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF) mediates eosinophil survival in vitro. Am J Respir Cell Mol Biol 1989; 1: 289-295.
17. Spry CJF. The natural history of eosinophils. In: Smith H, Cook RM, eds. Immunopharmacology of Eosinophils. London, Academic Press, 1993; pp. 1-9.
18. Rothenberg ME, Owen WF, Silberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3. J Clin Invest 1988; 81: 1986-1992.
19. Rothenberg ME, Petersen J, Stevens RL, et al. Interleukin-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143: 2311-2316.
20. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after provocation. Am Rev Respir Dis 1989; 139: 806-817.
21. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1: 520-524.
22. Hemler ME, Elices MJ, Parker C, Takada Y. Structure of the integrin VLA-4 and its cell/cell and cell/matrix adhesion functions. Immunol Rev 1990; 114: 45-65.
23. Yamada A, Nojima Y, Sugita K, Dang NH, Schlossman SF, Morimoto C. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum free culture system. Eur J Immunol 1991; 21: 319-325.
24. Anwar AR, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993; 177: 839-843.
25. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987; 326: 403-405.
26. Kita H, Ohnish T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte/macrophage colony-stimulating factor and interleukin-3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991; 174: 745-748.
27. Weller PF. Lipid, peptide and cytokine mediators elaborated by eosinophils. In: Smith H, Cook RM, eds. Immunopharmacology of Eosinophils. London, Academic Press, 1993; pp. 25-42.
28. Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell IL-4, IL-5, and IFN-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148: 401-406.